Opportunity Information: Apply for PA 13 336
Apply for PA 13 336
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Neuroscience Research on Drug Abuse (R03)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Aug 26, 2013 and posted on Aug 26, 2013.
- Applicants must submit their applications by Jan 7, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $100,000.00 in funding.
- Eligible applicants include: Native American tribal governments (Federally recognized) Private institutions of higher education For profit organizations other than small businesses Public and State controlled institutions of higher education City or township governments Small businesses County governments Independent school districts Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled Additional Information on Eligibility for clarification) State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Neuroscience Research on Drug Abuse (R03) opportunity (Funding Opportunity Number PA 13-336) is a discretionary NIH grant program focused on improving scientific understanding of how drug abuse and addiction change the brain and, in turn, influence behavior. The central idea behind the announcement is that substance use is not only a behavioral or social issue, but also a biological one that can produce widespread and sometimes lasting alterations in brain structure and function. The funding opportunity calls for research that can explain these brain changes, clarify the neurobiological mechanisms that drive addictive behavior, and ultimately point to better strategies for prevention and treatment. A major emphasis is placed on the brain and behavioral adaptations that occur during chronic drug exposure, the withdrawal period, and relapse, since these phases are closely tied to the persistence of addiction and the difficulty many people experience when trying to stop using substances.
The announcement is designed to support neuroscience-oriented projects that investigate the biological underpinnings of drug abuse and addiction using basic, translational, or clinical approaches. In practice, this means applicants can propose studies ranging from foundational laboratory work that identifies neural circuits, cellular processes, or molecular pathways affected by drugs, to translational research that bridges preclinical findings to human relevance, and clinical studies that directly examine brain-behavior relationships in people. The broader goal is to generate mechanistic insights that can reveal actionable targets, such as specific neural systems or biological processes that could be modulated through medications, behavioral interventions, neuromodulation, or other therapeutic approaches. By focusing on mechanisms rather than only outcomes, the program aims to strengthen the scientific basis for interventions that prevent the development of addiction, reduce harmful use, improve recovery, and decrease relapse risk.
This opportunity uses the NIH R03 mechanism, which is typically intended for small, focused research projects, pilot studies, feasibility work, or other tightly scoped efforts that can produce meaningful results with limited resources. The listed award ceiling is $100,000, and the announcement indicates there is no cost sharing or matching requirement. The program falls under the health and education activity categories and is associated with CFDA number 93.279 (Drug Abuse and Addiction Research Programs). The funding instrument type is a grant.
Eligibility is broad and includes many types of U.S.-based organizations and governments, such as public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations (including those with and without 501(c)(3) status), small businesses, for-profit organizations other than small businesses, independent school districts, and various local and state government entities (including county governments, city or township governments, special district governments, and public housing authorities/Indian housing authorities). The announcement also includes Native American tribal governments (federally recognized) and tribal organizations (including those not federally recognized), as well as tribally controlled colleges and universities. In addition, it explicitly allows applications from non-U.S. entities and foreign organizations and institutions, and notes that foreign components of U.S. organizations are allowed as defined by NIH policy. It also identifies specific categories such as HBCUs, Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, and Asian American and Native American Pacific Islander-serving institutions, along with faith-based or community-based organizations and U.S. territories or possessions, reflecting an intent to make the funding accessible across a wide range of institutional settings.
Key administrative details in the source record include a posted date and creation date of August 26, 2013, with an original and current closing date of January 7, 2017, and an archive date of February 7, 2017, indicating the announcement is no longer active but remains useful as a reference for the goals and structure of this funding line. The issuing agency is the National Institutes of Health. For official details and the full text of the announcement, the record points to the NIH Grants Guide page at http://grants.nih.gov/grants/guide/pa-files/PA-13-336.html, and provides NIH Office of Extramural Research (OER) webmaster contacts for access or linking issues (FBOWebmaster@OD.NIH.GOV).
FAQs: Neuroscience Research on Drug Abuse (R03) (PA-13-336)
What is the Neuroscience Research on Drug Abuse (R03) opportunity?
It is a discretionary NIH grant opportunity (Funding Opportunity Number PA-13-336) focused on neuroscience research that improves scientific understanding of how drug abuse and addiction change the brain and how those brain changes influence behavior.
What is the main scientific focus of this funding opportunity?
The program emphasizes the idea that substance use is not only a behavioral or social issue, but also a biological one. It supports research that explains alterations in brain structure and function caused by drug abuse and addiction, clarifies neurobiological mechanisms driving addictive behavior, and helps point toward better prevention and treatment strategies.
Which phases of addiction are especially emphasized?
A major emphasis is placed on brain and behavioral adaptations during chronic drug exposure, the withdrawal period, and relapse. These phases are highlighted because they are closely tied to the persistence of addiction and the difficulty many people experience when trying to stop using substances.
What kinds of research approaches are supported (basic, translational, clinical)?
The announcement is designed to support neuroscience-oriented projects using basic, translational, or clinical approaches. This includes foundational laboratory work (for example, identifying neural circuits, cellular processes, or molecular pathways affected by drugs), translational studies that bridge preclinical findings to human relevance, and clinical studies examining brain-behavior relationships in people.
Does the program require studies to focus on mechanisms rather than only outcomes?
Yes. A core goal is to generate mechanistic insights (not only outcome descriptions) that can reveal actionable targets, such as specific neural systems or biological processes that could be modulated through interventions.
What types of intervention targets or downstream applications are implied?
The program aims to strengthen the scientific basis for interventions that prevent addiction development, reduce harmful use, improve recovery, and decrease relapse risk. It highlights the potential to identify actionable targets that could be modulated through medications, behavioral interventions, neuromodulation, or other therapeutic approaches.
What grant mechanism is used for this opportunity?
This opportunity uses the NIH R03 mechanism, which is typically intended for small, focused research projects, pilot studies, feasibility work, or other tightly scoped efforts designed to produce meaningful results with limited resources.
What is the award ceiling for this R03 opportunity?
The listed award ceiling is $100,000.
Is cost sharing or matching required?
No. The announcement indicates there is no cost sharing or matching requirement.
What is the funding instrument type?
The funding instrument type is a grant.
Which agency issues this opportunity?
The issuing agency is the National Institutes of Health (NIH).
What activity categories are associated with this opportunity?
The source record lists the activity categories as health and education.
What CFDA number is associated with this program?
The opportunity is associated with CFDA number 93.279 (Drug Abuse and Addiction Research Programs).
Who is eligible to apply?
Eligibility is broad and includes many types of U.S.-based organizations and governments, including: public and state-controlled institutions of higher education; private institutions of higher education; nonprofit organizations (with or without 501(c)(3) status); small businesses; for-profit organizations other than small businesses; independent school districts; and various local and state government entities (including county governments, city or township governments, special district governments, and public housing authorities/Indian housing authorities).
Are tribal governments and tribal organizations eligible?
Yes. The announcement includes Native American tribal governments (federally recognized) and tribal organizations (including those not federally recognized), as well as tribally controlled colleges and universities.
Are U.S. territories or possessions included in eligibility?
Yes. The eligibility list explicitly includes U.S. territories or possessions.
Are faith-based or community-based organizations eligible?
Yes. The eligibility list includes faith-based or community-based organizations.
Does the opportunity encourage applications from specific types of institutions?
The eligibility categories specifically identify institution types such as HBCUs, Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, and Asian American and Native American Pacific Islander-serving institutions, indicating an intent to make funding accessible across a wide range of institutional settings.
Can non-U.S. entities or foreign organizations apply?
Yes. The announcement explicitly allows applications from non-U.S. entities and foreign organizations and institutions.
Are foreign components of U.S. organizations allowed?
Yes. The announcement notes that foreign components of U.S. organizations are allowed as defined by NIH policy.
Is this funding opportunity still active?
No. The administrative details indicate an original and current closing date of January 7, 2017, and an archive date of February 7, 2017, meaning the announcement is no longer active. It may still be useful as a reference for the goals and structure of this funding line.
When was the opportunity posted?
The source record lists both the posted date and creation date as August 26, 2013.
Where can I find the official announcement text?
The record points to the NIH Grants Guide page for the full text: http://grants.nih.gov/grants/guide/pa-files/PA-13-336.html
Who do I contact for access or linking issues related to the official NIH page?
The record provides NIH Office of Extramural Research (OER) webmaster contact information for access or linking issues: FBOWebmaster@OD.NIH.GOV
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: Neuroscience Research on Drug Abuse (R01)
Previous opportunity: Neuroscience Research on Drug Abuse (R21)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 13 336
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 13 336) also looked into and applied for these:
| Funding Opportunity |
|---|
| Neuroscience Research on Drug Abuse (R01) Apply for PA 13 338 Funding Number: PA 13 338 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Mechanisms of Alcohol and Stimulant Co Addiction (R01) Apply for PA 13 339 Funding Number: PA 13 339 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Mechanisms of Alcohol and Stimulant Co Addiction (R21) Apply for PA 13 340 Funding Number: PA 13 340 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Early Career Award in Chemistry of Drug Abuse and Addiction (ECHEM) (R21/R33) Apply for PAR 13 350 Funding Number: PAR 13 350 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| National Institute on Drug Abuse National Early Warning System (NEWS) Coordinating Center (U01) Apply for RFA DA 14 015 Funding Number: RFA DA 14 015 Agency: National Institutes of Health Category: Education Health Funding Amount: $900,000 |
| Research Answers to NCIs Provocative Questions Group A (R01) Apply for RFA CA 13 016 Funding Number: RFA CA 13 016 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Answers to NCIs Provocative Questions Group A (R21) Apply for RFA CA 13 017 Funding Number: RFA CA 13 017 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research Answers to NCIs Provocative Questions Group B (R01) Apply for RFA CA 13 018 Funding Number: RFA CA 13 018 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Answers to NCIs Provocative Questions Group C (R01) Apply for RFA CA 13 020 Funding Number: RFA CA 13 020 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Answers to NCIs Provocative Questions Group D (R01) Apply for RFA CA 13 022 Funding Number: RFA CA 13 022 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Answers to NCIs Provocative Questions Group D (R21) Apply for RFA CA 13 023 Funding Number: RFA CA 13 023 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research Answers to NCIs Provocative Questions Group B (R21) Apply for RFA CA 13 019 Funding Number: RFA CA 13 019 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research Answers to NCIs Provocative Questions Group C (R21) Apply for RFA CA 13 021 Funding Number: RFA CA 13 021 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research Answers to NCIs Provocative Questions Group E (R01) Apply for RFA CA 13 024 Funding Number: RFA CA 13 024 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Answers to NCIs Provocative Questions Group E (R21) Apply for RFA CA 13 025 Funding Number: RFA CA 13 025 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Interpreting Variation in Human Non Coding Genomic Regions Using Computational Approaches and Experimental Assessment (R01) Apply for RFA HG 13 013 Funding Number: RFA HG 13 013 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Planning for a National Center for Particle Beam Radiation Therapy Research (P20) Apply for PAR 13 371 Funding Number: PAR 13 371 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Research on Malignancies in the Context of HIV/AIDS (R21) Apply for PA 13 378 Funding Number: PA 13 378 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research on Malignancies in the Context of HIV/AIDS (R01) Apply for PA 13 377 Funding Number: PA 13 377 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Sub Saharan African Collaborative HIV and Cancer Consortia (U54) Apply for RFA CA 13 010 Funding Number: RFA CA 13 010 Agency: National Institutes of Health Category: Education Health Funding Amount: $750,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 13 336", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.